Clinical Trials Browser

Phase 2 × OTHER × Neoadjuvant Therapy × Clear all

NCT07054242 2025-10-01

A Prospective, Single-center, Phase II Study of Sacituzumab Tirumotecan in Combination With Pembrolizumab for Neoadjuvant Treatment of Triple-Negative Breast Cancer (TNBC)

Phase 2 Not yet recruiting

Neoadjuvant Therapy

NCT05376722 2023-01-05

A Study of Pamiparib Combined With Abiraterone Acetate in Neoadjuvant Treatment of Prostate Cancer

Phase 2 Unknown

Neoadjuvant Therapy